Regencell Bioscience Holdings Limited Ordinary Shares RGC
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T02:00:49.742Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:59:16.572033331Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:00:48.721042+00:00
Regencell Bioscience Holdings Limited Ordinary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 5.19 | 477.7% | 30.4% | |||
| 40Δ | 5.49 | 449.8% | 27.1% | |||
| 45Δ | 6.30 | 469.4% | 41.7% | 5.79 | 422.0% | 23.9% |
| 50Δ | 6.08 | 518.8% | 41.4% | 6.09 | 394.2% | 20.6% |
| 55Δ | 5.85 | 568.2% | 41.1% | 6.39 | 366.3% | 17.4% |
| 60Δ | 5.63 | 617.6% | 40.7% | 6.69 | 338.5% | 14.1% |
| 65Δ | 5.40 | 667.0% | 40.4% | 6.99 | 310.7% | 10.8% |
| 70Δ | 5.18 | 716.4% | 40.0% | 7.29 | 282.9% | 7.6% |
| 75Δ | 4.86 | 735.8% | 37.6% | |||
| 80Δ | 4.21 | 649.4% | 28.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.19
- IV
- 477.7%
- B/E move
- 30.4%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.49
- IV
- 449.8%
- B/E move
- 27.1%
45Δ
- Pseudo strike
- 6.30
- IV
- 469.4%
- B/E move
- 41.7%
- Pseudo strike
- 5.79
- IV
- 422.0%
- B/E move
- 23.9%
50Δ
- Pseudo strike
- 6.08
- IV
- 518.8%
- B/E move
- 41.4%
- Pseudo strike
- 6.09
- IV
- 394.2%
- B/E move
- 20.6%
55Δ
- Pseudo strike
- 5.85
- IV
- 568.2%
- B/E move
- 41.1%
- Pseudo strike
- 6.39
- IV
- 366.3%
- B/E move
- 17.4%
60Δ
- Pseudo strike
- 5.63
- IV
- 617.6%
- B/E move
- 40.7%
- Pseudo strike
- 6.69
- IV
- 338.5%
- B/E move
- 14.1%
65Δ
- Pseudo strike
- 5.40
- IV
- 667.0%
- B/E move
- 40.4%
- Pseudo strike
- 6.99
- IV
- 310.7%
- B/E move
- 10.8%
70Δ
- Pseudo strike
- 5.18
- IV
- 716.4%
- B/E move
- 40.0%
- Pseudo strike
- 7.29
- IV
- 282.9%
- B/E move
- 7.6%
75Δ
- Pseudo strike
- 4.86
- IV
- 735.8%
- B/E move
- 37.6%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 4.21
- IV
- 649.4%
- B/E move
- 28.0%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 193.68% | |
| 215.73% |
Drug Manufacturers - Specialty & Generic
SCYX
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
More →SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered…
More →SUPN
Description unavailable
More →TAK
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer…
More →TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North…
More →TKNO
Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements that facilitate…
More →